Immutep Limited, Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia; ABN: 90 009 237 889 Immutep receives ~A$0.86 million R&D Tax Incentive SYDNEY, AUSTRALIA – September 30, 2026 — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a...
Immutep receives Australian R&D Tax Incentive
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immutep
- Change to American Depositary Share Ratio
- Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)
- Immutep Outlines Focused Development Strategy for Efti
- S&P DJI Announces September 2026 Quarterly Rebalance
- Appendix 4E & 2026 Full Year Statutory Accounts
Later from Immutep
- Immutep Receives ~A$0.86 Million R&D Tax Incentive
- Application for quotation of securities - IMM
- Change of Director's Interest Notice - P Meyers
- Resignation of Non-Executive Director
- Notification of cessation of securities - IMM
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep